MRT (MRT) financial statements
MRT reported revenue of $33,582 in fiscal 2025, down 78.9% a year over 4 years.
Net income was -$41M and the operating margin -84962.5%, against -53.3% in 2021.
Free cash flow was -$15M, and the company returned $367,632 in net buybacks.
The diluted share count rose 128% over the period (dilution).
Revenue and free cash flow
Fiscal years, $ billions.
Income statement
Fiscal years, from MRT's 10-K filings with the SEC.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $17M | $436,156 | $664,504 | $417,845 | $33,582 |
| Cost of revenue | $17M | $27M | $24M | $22M | $15M |
| Research and development | $1M | $2M | $2M | $2M | $3M |
| Selling, general and admin | $7M | $5M | $22M | $59M | $41M |
| Operating income | -$9M | -$15M | -$31M | -$65M | -$29M |
| Pre-tax income | -$14M | -$14M | -$34M | -$74M | -$41M |
| Income tax | $887,648 | — | — | — | — |
| Net income | -$14M | -$837,116 | -$34M | -$74M | -$41M |
| EPS (diluted) | -$0.42 | -$0.32 | -$0.67 | -$1.25 | -$0.53 |
| Diluted shares | 34M | 44M | 51M | 59M | 78M |
| Operating margin | -53.3% | -3411.9% | -4605.5% | -15630.2% | -84962.5% |
| Net margin | -85.1% | -191.9% | -5088.7% | -17681.4% | -123417.4% |
Balance sheet
Fiscal years, from MRT's 10-K filings with the SEC.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash and short-term investments | $610,926 | $251,865 | $19M | $5M | $8M |
| Receivables | — | $375,154 | $188,358 | $203,522 | $503,820 |
| Inventory | — | $3M | $3M | $2M | $2M |
| Total current assets | $758,253 | $323,356 | $26M | $11M | $14M |
| Property, plant and equipment | — | $19M | $14M | $5M | $3M |
| Total assets | $147M | $149M | $40M | $20M | $30M |
| Total current liabilities | $706,224 | $3M | $18M | $11M | $14M |
| Long-term debt | — | $16M | $55M | $70M | $82M |
| Total liabilities | $6M | $8M | $73M | $82M | $97M |
| Shareholders' equity | -$2M | -$5M | -$33M | -$61M | -$67M |
| Net debt | -$610,926 | $23M | $46M | $70M | $78M |
Cash flow
Fiscal years, from MRT's 10-K filings with the SEC.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | -$4M | -$359,061 | -$15M | -$25M | -$15M |
| Capital spending | — | — | $652,374 | $332,354 | $485,329 |
| Free cash flow | — | — | -$16M | -$25M | -$15M |
| Stock-based compensation | $868,756 | $2M | $2M | $36M | $11M |
| Share buybacks (net) | — | — | — | — | -$367,632 |
| Free cash flow margin | — | — | -2335.3% | -6081.1% | -45460.6% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for MRT.
Open MRT in InvestinglyQuestions
What was MRT's revenue in 2025?
$33,582 in fiscal 2025, from its 10-K filing.
How much free cash flow does MRT generate?
-$15M in fiscal 2025 (operating cash flow minus capital spending).
From MRT's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.